D-0699-2026 Class II Ongoing

Recalled by Blaine Labs Inc — Santa Fe Springs, CA

FDA drug recall D-0699-2026 was initiated by Blaine Labs Inc on Apr 8, 2026 and is designated Class II. Reason for recall: CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated The recall status is ongoing. Affected quantity: 5,555 bottles and tubes.

Recall details

Product Type
Drugs
Report Date
Jul 8, 2026
Initiation Date
Apr 8, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,555 bottles and tubes

Product description

Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl OZ (16 mL) bottle, long pointy cap, NDC 63347-120-02; (b) 3.0 Fl OZ (85 g) tube, with short twist cap, NDC 63347-120-01; Manufactured By: Blaine Labs, Inc. 11037 Lockport Place, Santa Fe Springs, CA 90670,

Reason for recall

CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated

Distribution pattern

Nationwide in the USA

Code information

Lots: (a) 1 oz - BL3435, Exp 11/06/26; BL3525, Exp 08/07/27. (b) 3 oz- Lots # BL3435, 11/06/26 & BL3525, 08/07/27

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0699-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0699-2026. Report a data issue: hello@regdatalab.com.